M. Samuels

Immunotherapy of malignant disease: The use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes

E. Krementz, E. Benes, P. Mansell, 1974, Cancer.

Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer

P. Thaker, M. Flint, C. Cilibrasi, 2023, Brain, Behavior, and Immunity.

Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).

R. Caprioli, S. Wallace, R. Benjamin, 1983, Cancer research.

A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.

C. Hamilton, T. Sterling, A. Vernon, 2002, American journal of respiratory and critical care medicine.

Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer

P. Thaker, M. Flint, C. Cilibrasi, 2023, Brain, Behavior, and Immunity.